Back to Hompage
Hebrew  |  English  
 
 
     
 
 
Homepage
Printer Friendly Version    
  My TASE  
 
CAN FITE BIOPHARMA LTD
Market Data Charts Historical Prices Statistics Profile Analysis & Ratios Disclosures
www.canfite.com
   Issuer No.   
Corporate No.
   Market Cap (20/07/2017)   
   1272   
   512022153   
    105,451 NIS thousands   
   TASE Supersector
   TASE Sector   
   TASE Subsector   
   Indices   
   High-Tech   
   Biomed   
   Biotechnology   
   TA-SME60, TA-Biomed Index, TA Global-BlueTech, TA-AllShare, TA-Rimon, TA-SME150, Additional Indices   
  Contact Details :
  Phone : 03-9241114
  Fax : 03-9249378
  MOTTI@CANFITE.CO.IL
   Interested Parties:
   Interested Parties:
List of Interested Parties  >
List of Securities  >
Indices  >
Index Adjusted Data for Company Securities  >
Financial Statements – Key Data (NIS thousands) **
 March 2017March 2016Yearly 2016
Balance Sheet
Total Assets
44,422
62,104
39,109
Current Assets
44,188
61,823
38,867
Non Current Assets
234
281
242
Shareholders Equity
21,166
35,284
14,902
Of which Minority Interest
137
501
33
Current Liabilities
6,955
7,815
9,629
Long-Term Liabilities
16,301
19,005
14,578
Profit & Loss Statement
Revenues
266
214
652
Gross Profit
266
214
652
Operating Income
-7,039
-6,227
-33,211
Income Before Tax
-4,554
-5,787
-26,897
Net Income
-4,554
-5,787
-27,009
Income Attributable to Shareholders
-4,457
-5,803
-27,486
Earnings per Share
-0.12
-0.21
-0.96
Additional Data
Dividends
---
---
---
Net cash flow generated by operating activities
---
---
---
Financial Ratios
Market to book value
5.01
---
---
Price-Earning Ratio
Loss
---
---
Equity-Assets Ratio
47.3 %
---
38.0 %
Return on Equity
-93.7 %
---
-99.7 %
 Export Table Data 
Note: The financial statements data have been obtained from A-Online and they were compiled and processed by it. The data have not been examined or audited by the Stock Exchange and they are presented as given to the Stock Exchange by A-Online.
The binding data are those appearing in the financial statements published by the Company. Without derogating from the provisions of the use agreement , the Stock Exchange is not liable for any fault, error, mistake or inaccuracy in the data presented. Financial statements published in foreign currency are translated to NIS according to the exchange rate at the date of the financial statements.
Financial Ratios: Market Capitalization – as of end of previous trading day; Net income – attributable to the Shareholders (Trailing Twelve Months); Shareholders' Equity- attributable to the Shareholders (average 12 months start and end of period).